Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Change in Accured Expenses (2011 - 2014)

InspireMD posted quarterly Change in Accured Expenses of $690000.0 for Q1 2014, up 171.65% year-on-year from $254000.0 in Q1 2013, and up 893.1% on a QoQ basis from -$87000.0 in Q3 2013.

InspireMD (NSPR) has 4 years of Change in Accured Expenses data on file, last reported at $690000.0 in Q1 2014.

  • For the quarter ending Q1 2014, Change in Accured Expenses rose 171.65% year-over-year to $690000.0; the trailing twelve-month figure through Mar 2014 stood at $1.5 million (up 859.69% YoY), and the FY2014 full-year result was $1.4 million, up 4746.67% from the prior year.
  • Change in Accured Expenses for Q1 2014 stood at $690000.0, up from -$87000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $690000.0 in Q1 2014 and bottomed at -$338000.0 in Q4 2011.
  • The 4-year median for Change in Accured Expenses is -$19000.0 (2011), against an average of $72111.1.
  • The widest annual swing landed in 2012, when Change in Accured Expenses plunged 1489.47%; it then surged 171.65% in 2014.
  • A 4-year view of Change in Accured Expenses shows it stood at -$338000.0 in 2011, then increased by 4.73% to -$322000.0 in 2012, then soared by 72.98% to -$87000.0 in 2013, then surged by 893.1% to $690000.0 in 2014.
  • The last three Change in Accured Expenses figures came in at $690000.0 (Q1 2014), -$87000.0 (Q3 2013), and $594000.0 (Q2 2013), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -654.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 703.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -347.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 21.07 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 145.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -250.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 74.30 Mn
10 InspireMD 64.01 Mn 9.80 Mn 1.18 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2014 690,000.00
Mar 31, 2014 690,000.00
Sep 30, 2013 -87,000.00
Sep 30, 2013 -87,000.00
Jun 30, 2013 594,000.00
Jun 30, 2013 594,000.00
Mar 31, 2013 254,000.00
Mar 31, 2013 254,000.00
Dec 31, 2012 -322,000.00
Dec 31, 2012 -322,000.00
Sep 30, 2012 -302,000.00
Sep 30, 2012 -302,000.00
Mar 31, 2012 179,000.00
Mar 31, 2012 179,000.00
Dec 31, 2011 -338,000.00
Dec 31, 2011 -338,000.00
Sep 30, 2011 -19,000.00
Sep 30, 2011 -19,000.00